Browse > Home / FDA News / Largest Drugmakers Would Bear the Brunt of New Fees in Baucus Proposal

Largest Drugmakers Would Bear the Brunt of New Fees in Baucus Proposal

September 17, 2009

Largest Drugmakers Would Bear the Brunt of New Fees in Baucus Proposal
Drugmakers marketing products for the elderly probably will face the highest recurring with the year fees under a $2.3 billion annual program designed to withstand pay for Sen. Max Baucus’ (D-Mont.) healthcare examine legislation, Jack Calfee, an American Enterprise Institute economist who studies the drug industry and the FDA, before-mentioned, adding that drugmakers could offset the effect by raising prices. The America’s Healthy Future Act, released Wednesday upon Capitol Hill, would give the Treasury secretary the authority to estimate anniversary fees for drugmakers based on the amount of sales of branded recipe drugs sold to Medicare, Medicaid, Veterans Health Administration and Tricare.

Written by Samanta · Filed Under FDA News